Polymed Limited Revenue and Competitors
Estimated Revenue & Valuation
- Polymed Limited's estimated annual revenue is currently $85.1M per year.
- Polymed Limited's estimated revenue per employee is $231,850
Employee Data
- Polymed Limited has 367 Employees.
- Polymed Limited grew their employee count by 32% last year.
Polymed Limited's People
Name | Title | Email/Phone |
---|---|---|
1 | Area Business Manager | Reveal Email/Phone |
Polymed Limited Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $86.6M | 335 | 18% | N/A | N/A |
#2 | $369.5M | 668 | -11% | $974.7M | N/A |
#3 | $1M | 3 | 0% | N/A | N/A |
#4 | $258.8M | 1031 | 18% | N/A | N/A |
#5 | $136M | 542 | 8% | N/A | N/A |
#6 | $19.8M | 66 | 2% | N/A | N/A |
#7 | $51.7M | 186 | 10% | N/A | N/A |
#8 | $40.9M | 155 | 16% | N/A | N/A |
#9 | $85.1M | 367 | 32% | N/A | N/A |
#10 | $40.4M | 115 | -13% | N/A | N/A |
What Is Polymed Limited?
Polymed Limited is a medical devices company based out of Western Ave, Cardiff, United Kingdom.
keywords:N/AN/A
Total Funding
367
Number of Employees
$85.1M
Revenue (est)
32%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Polymed Limited News
2022-04-20 - Non-Operative Spine Care Market Size 2022-2029| Key ...
... Market Size 2022-2029| Key Players Klein Tools, Polymed Medical Devices, ... not limited to,revenue,production, consumption, gross margin and price.
2022-04-19 - Global Blood Banking Devices Market 2022 Business ...
Bio-Rad Laboratories, Inc. Hindustan Syringes and Medical Devices Ltd. Polymed Medical Devices; Roche Holdings AG; Siemens Healthcare...
2022-04-17 - Blood Banking Devices Market Size, Scope And Forecast ...
... Laboratories Hindustan Syringes and Medical Devices Ltd., Polymed Medical Devices, Terumo Corporation and Thermo Fisher Scientific, Inc.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $107.8M | 373 | 16% | N/A |
#2 | $126M | 390 | 22% | N/A |
#3 | $79.5M | 390 | N/A | N/A |
#4 | $136.7M | 405 | 13% | N/A |
#5 | $63.1M | 407 | 6% | N/A |